Status:
COMPLETED
Effect of Selenium on Succinylcholine-Induced POM
Lead Sponsor:
Assiut University
Conditions:
Postoperative Myalgia
Eligibility:
All Genders
20-40 years
Phase:
PHASE2
PHASE3
Brief Summary
For more than 60 years, succinylcholine is still being administered as the selective relaxant for rapid sequence intubation by anesthesiologists in many countries. It has been shown to possess unique ...
Detailed Description
Eligibility and type of the study: This prospective randomized placebo-controlled double-blind study will be conducted after approval from the Institutional Ethics Committee and obtaining written info...
Eligibility Criteria
Inclusion
- Adult Patients aged 20-40 years, either sex.
- ASA physical status I or II.
- Elective sinuscopic procedures.
- Moderate to severe myalgia grade 2,3.
Exclusion
- Abnormal renal and liver function tests.
- History of chronic pain, and regular medication with SNRI or analgesics (excluding acetaminophen and nonsteroidal anti-inflammatory drugs).
- patients with a history of seizure disorders, hyperkalemia, systemic illness like hypertension, diabetes, increased intracranial and intraocular pressure, pregnant or breast-feeding females.
- Any patients with previous history of drug induced muscle pain.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03476044
Start Date
June 1 2018
End Date
March 31 2020
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt, 71515